NCT01834313

Brief Summary

The purpose of this study is to evaluate the monetary value of patient-centrednes in health care by determining a willingness-to-pay for more patient-centredness care for both patients and health insurers

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 17, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

July 23, 2013

Status Verified

July 1, 2013

Enrollment Period

9 months

First QC Date

April 12, 2013

Last Update Submit

July 22, 2013

Conditions

Willingness-to-payPatient-centredness

Keywords

Willingness-to-payPatient-centrednessHealth insurersFertility care

Outcome Measures

Primary Outcomes (1)

  • Willingness-to-pay for patient-centred care

    A willingness-to-pay for patient-centred care for both patients and health insurers

    6 months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient who are under treatment for their fertility problem and underwent at least one treatment in one of 10 Dutch clinics. All healthcare purchasers from the 5 large Dutch health insurer companies

You may qualify if:

  • Patients undergoing MAR-treatment (ovulation induction, intra-uterine inseminations, in vitro fertilization, or intra-cytoplasmic sperm injection)
  • All healthcare purchasers working at one of the 5 large Dutch health insurer companies.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud University Medical Centre

Nijmegen, Gelderland, 6500 HB, Netherlands

RECRUITING

Related Publications (1)

  • Huppelschoten AG, Verkerk EW, Appleby J, Groenewoud H, Adang EM, Nelen WL, Kremer JA. The monetary value of patient-centred care: results from a discrete choice experiment in Dutch fertility care. Hum Reprod. 2014 Aug;29(8):1712-20. doi: 10.1093/humrep/deu122. Epub 2014 Jun 4.

    PMID: 24903199DERIVED

Study Officials

  • J AM Kremer, MD, PhD

    Radboud University Medical Centre, Nijmegen

    STUDY CHAIR

  • W L Nelen, MD, PhD

    Radboud University Medical Centre, Nijmegen

    STUDY DIRECTOR

  • E MM Adang, PhD

    Radboud University Medical Centre, Nijmegen

    STUDY DIRECTOR

  • A G Huppelschoten, MD

    Radboud University Medical Centre, Nijmegen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, Principal Investigator

Study Record Dates

First Submitted

April 12, 2013

First Posted

April 17, 2013

Study Start

November 1, 2012

Primary Completion

August 1, 2013

Study Completion

October 1, 2013

Last Updated

July 23, 2013

Record last verified: 2013-07

Locations

NL(1)